ArticleOncotarget2017

Growth hormone-releasing hormone antagonist inhibits the invasiveness of human endometrial cancer cells by down-regulating twist and N-cadherin expression.

Hsien-Ming Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.